Label Changes for:
Novothyrox (levothyroxine sodium) Tablets
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- March 2009
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.|
- agents such as iron and calcium supplements and antacids can decrease the absorption of levothyroxine tablets
- instructions for reporting side effects to FDA
- drug-drug interaction between levothyroxine and orlistat